| Date | Form | Description | Docs | XBRL | Pages |
| 09/14/12 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/14/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
27 |
| 09/11/12 | 8-K | Current report filing |
|
8 | |
| 09/10/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/10/12 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
28 | |
| 09/10/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/05/12 | 8-K | Current report filing |
|
8 | |
| 08/30/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/27/12 | 8-K | Current report filing |
|
24 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...